Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5141]
News [14942]
Articles [105]
Editorials [3]
Conferences [247]
elearning [21]
Challenges and solutions in PD-L1 testing in NSCLC
Prof Frédérique Penault-Llorca - Centre Jean Perrin, Clermont-Ferrand, France
Challenges and solutions in PD-L1 testing in NSCLC ( Prof Frédérique Penault-Llorca - Centre Jean Perrin, Clermont-Ferrand, France )
5 Mar 2021
Managing immune-related adverse events
Catherine Cochez - CHU Strasbourg, France
Managing immune-related adverse events ( Catherine Cochez - CHU Strasbourg, France )
5 Mar 2021
ERAS in gynaecological oncology from developed to developing countries
Prof Geetu Bhandoria - Command Hospital, Kolkata, India
ERAS in gynaecological oncology from developed to developing countries ( Prof Geetu Bhandoria - Command Hospital, Kolkata, India )
4 Mar 2021
Managing the treatment of NSCLC patients during the COVID-19 pandemic (DE)
Dr Giuseppe Giaccone, Dr Marina Garassino
Managing the treatment of NSCLC patients during the COVID-19 pandemic (DE) ( Dr Giuseppe Giaccone, Dr Marina Garassino )
2 Mar 2021
Promise of personalised medicine for patients with prostate cancer
Prof Eleni Efstathiou, Prof Alicia Morgans, Prof Karim Fizazi and Prof Gerhardt...
Promise of personalised medicine for patients with prostate cancer ( Prof Eleni Efstathiou, Prof Alicia Morgans, Prof Karim Fizazi and Prof Gerhardt Attard )
26 Feb 2021
Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell...
Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology...
Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma ( Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology, Nashville, USA )
26 Feb 2021
SEMS trial: result of a prospective, multi-institutional phase II clinical...
Dr Sia Daneshmand - University of Southern California, Los Angeles, USA
SEMS trial: result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma ( Dr Sia Daneshmand - University of Southern California, Los Angeles, USA )
24 Feb 2021
Sequencing endocrine treatment in metastatic luminal breast cancer and...
Prof Hope Rugo - University of California San Francisco, San Francisco, USA
Sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment of metastatic BC ( Prof Hope Rugo - University of California San Francisco, San Francisco, USA )
24 Feb 2021
Latest developments in the treatment of mRCC
Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald
Latest developments in the treatment of mRCC ( Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald )
24 Feb 2021
Long term response to apalutamide and other updates impacting patients with...
Prof Axel Merseburger and Prof Matthew Smith
Long term response to apalutamide and other updates impacting patients with nmCRPC from ASCO GU 2021 ( Prof Axel Merseburger and Prof Matthew Smith )
22 Feb 2021
Current treatment standards for primary ovarian cancer
Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA
Current treatment standards for primary ovarian cancer ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )
18 Feb 2021
Evolving medical treatment in advanced/recurrent endometrial cancer
Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA
Evolving medical treatment in advanced/recurrent endometrial cancer ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )
18 Feb 2021

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation